HomeAI · summaries
Storia in 10 fonti
FT: AbbVie está perto de comprar Apogee Therapeutics por US$ 11 bi
Negócio chega em meio a aumento de compras de companhias de biotecnologia e ao interesse das grandes farmacêuticas para reforçar desenvolvimento de remédios
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
markets.businessinsider.com
M&A News: AbbVie Lining up an $11B Deal for Eczema Drug Maker Apogee Therapeutics
Shares in biotechnology company Apogee Therapeutics (APGE) are set to start the new week off in great shape on reports that it could be swallowe...
- ·
wiwo.de
Pharmaindustrie: AbbVie wohl vor Übernahme von Biotechfirma Apogee Therapeutics
Der Pharmariese aus den USA plant offenbar den Kauf von Apogee Therapeutics. Das Angebot stellt einen deutlichen Aufschlag dar.
